Compounders Research Compare

Aclarion, Inc.(ACON)

Medical - Healthcare Information Services · Broomfield, CA

$2.31-0.03 (-1.28%)

Delayed quote: Oct 6, 2026, 11:24 AM EDT

About Aclarion, Inc.

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Broomfield, CA

11 employees

www.aclarion.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Brent Ness

View full financials

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T15:35:22.261Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:35:22.261Z.

Quote observation: 2026-10-06T15:24:41.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 6,658,277
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 16,285,462
TTM operating income · period ending 2026-06-30: -9,710,621

FMP input reference: 1aa4897ea94b4447735fa2b7e4a8bb5a18d1bcefabda34b81af7232f4abbcb6a

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ACON EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

ACON Competitors' EV/EBIT Ratio

Aclarion, Inc.

Current

Market Cap

$6.66M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Enveric Biosciences, Inc.

Market Cap

$6.58M

EV/EBIT Ratio

N/A

TTM Avg

1748.82x

3Y Avg

1748.82x

5Y Avg

1748.82x

Bolt Biotherapeutics, Inc.

Market Cap

$6.90M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Ensysce Biosciences, Inc.

Market Cap

$6.46M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Mangoceuticals, Inc.

Market Cap

$7.20M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NeuroSense Therapeutics Ltd.

Market Cap

$6.98M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Biomerica, Inc.

Market Cap

$6.27M

EV/EBIT Ratio

N/A

TTM Avg

471.11x

3Y Avg

281.60x

5Y Avg

221.14x

Co-Diagnostics, Inc.

Market Cap

$7.13M

EV/EBIT Ratio

N/A

TTM Avg

1.45x

3Y Avg

7.74x

5Y Avg

7.74x

Femasys Inc.

Market Cap

$6.16M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Curanex Pharmaceuticals Inc Common Stock

Market Cap

$7.26M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Aclarion, Inc. (ACON)	$6.66M	N/A	N/A	N/A	N/A
Enveric Biosciences, Inc. (ENVB)vs ›	$6.58M	N/A	1748.82x	1748.82x	1748.82x
Bolt Biotherapeutics, Inc. (BOLT)vs ›	$6.90M	N/A	N/A	N/A	N/A
Ensysce Biosciences, Inc. (ENSC)vs ›	$6.46M	N/A	N/A	N/A	N/A
Mangoceuticals, Inc. (MGRX)vs ›	$7.20M	N/A	N/A	N/A	N/A
NeuroSense Therapeutics Ltd. (NRSN)vs ›	$6.98M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.27M	N/A	471.11x	281.60x	221.14x
Co-Diagnostics, Inc. (CODX)vs ›	$7.13M	N/A	1.45x	7.74x	7.74x
Femasys Inc. (FEMY)vs ›	$6.16M	N/A	N/A	N/A	N/A
Curanex Pharmaceuticals Inc Common Stock (CURX)vs ›	$7.26M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/EBITDA EV/Sales Operating Income All Metrics